Gaber Batiha-Saber

Damanhur, BH 22511, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities.

Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities.

Journal: Cancer chemotherapy and pharmacology
Published: February 06, 2026

Common molecular signatures: the role of BDNF, melatonin, and orexin in the ASD-schizophrenia continuum.

Common molecular signatures: the role of BDNF, melatonin, and orexin in the ASD-schizophrenia continuum.

Journal: Molecular biology reports
Published: December 30, 2025

Targeting inflammaging in Alzheimer's disease: molecular pathways and emerging pharmacotherapies.

Targeting inflammaging in Alzheimer's disease: molecular pathways and emerging pharmacotherapies.

Journal: Inflammopharmacology
Published: December 13, 2025

The Protective Role of Aquaporin 4 (AQP4) in Temporal Lobe Epilepsy: Yes or No?

The Protective Role of Aquaporin 4 (AQP4) in Temporal Lobe Epilepsy: Yes or No?

Journal: Journal of molecular neuroscience : MN
Published: November 10, 2025

Colchicine in COVID-19: Mechanistic Insights and Clinical Uncertainties.

Colchicine in COVID-19: Mechanistic Insights and Clinical Uncertainties.

Journal: Reviews in medical virology
Published: October 23, 2025

The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.

The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 08, 2025

Role of insulin-like growth factor-1/2 and related signaling in parkinson's disease.

Role of insulin-like growth factor-1/2 and related signaling in parkinson's disease.

Journal: Metabolic brain disease
Published: August 22, 2025

Retraction notice to "Combination therapy with Hordeum vulgare, Elettaria cardamomum, and Cicer arietinum exhibited anti-diabetic potential through modulation of oxidative stress and proinflammatory cytokines" [Heliyon 10 (2024) e26126].

Retraction notice to "Combination therapy with Hordeum vulgare, Elettaria cardamomum, and Cicer arietinum exhibited anti-diabetic potential through modulation of oxidative stress and proinflammatory cytokines" [Heliyon 10 (2024) e26126].

Journal: Heliyon
Published: April 09, 2025

Corrigendum to "Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet" [Eur. J. Pharmacol. 995 (2025) 177419].

Corrigendum to "Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet" [Eur. J. Pharmacol. 995 (2025) 177419].

Journal: European journal of pharmacology
Published: April 07, 2025

Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer's mice model.

Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer's mice model.

Journal: Scientific reports
Published: March 29, 2025

Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy.

Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy.

Journal: The Journal of pharmacology and experimental therapeutics
Published: March 24, 2025

Editorial Expression of Concern to: The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective.

Editorial Expression of Concern to: The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective.

Journal: Acta neurologica Belgica
Published: February 28, 2025
Showing 1-12 of 60

Last Updated: 09/26/2026